Startup Creator Launched to Fill Europe’s Microbiome Translational Gap
With a €49M ($60M) Series A, the French firm eureKARE debuted this month with the…
28/05/2021 - 6 minutes
News and Trends
Delayed IPOs and Market Drops Batter Biotech Stocks
Stock markets worldwide have experienced painful instability in the last few months. As a result,…
25/05/2021 - 6 minutes
EU Approves Edible Insects for Humans but Roadblocks Remain
Europe is seeing a surge of interest in edible insect farming after an EU vote…
20/05/2021 - 6 minutes
Avantium and Carbios Capitalize on Growing Bioplastics Demand
As the EU phases out a wide range of single-use plastics this year, investor interest…
18/05/2021 - 5 minutes
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
Bluebird Bio Withdrawal Raises Gene Therapy Doubts in Europe
Last month, the US firm bluebird bio abandoned the sale of its gene therapy Zynteglo…
04/05/2021 - 5 minutes
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
27/04/2021 - 6 minutes
Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
21/04/2021 - 5 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
15/04/2021 - 5 minutes
DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
14/04/2021 - 5 minutes
